Manipal Hospitals, a leading healthcare network in Delhi NCR with facilities in Delhi, Gurugram, and Ghaziabad, has announced the appointment of Dr. Surender Kumar Dabas, one of India’s most distinguished robotic onco-surgeons, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
This strategic addition marks a significant step in enhancing advanced cancer care, particularly in robot-assisted surgical oncology, underscoring Manipal Hospitals’ commitment to providing cutting-edge, comprehensive cancer treatment.
With over 22 years of experience, Dr. Dabas is a pioneer in robotic head and neck cancer surgery in India. He has performed more than 30,000 cancer surgeries, including over 4,000 robotic procedures, making him one of the most accomplished robotic cancer surgeons in the country. His clinical expertise spans robotic surgeries for head and neck, thoracic, gynaecologic, urologic, gastrointestinal, colorectal, and breast cancers.
Welcoming him to the network, Mr. Pramod Alagharu, Regional COO – North-West Cluster, Manipal Hospitals, said:
“We are proud to welcome Dr. Surender Kumar Dabas and his highly skilled team of 150 medical professionals. His proficiency in managing complex oncological cases significantly strengthens our ability to offer world-class, robot-assisted cancer treatments that promote faster recovery and better patient outcomes.” Dr. Dabas expressed enthusiasm about his new role, stating: “I’m thrilled to join the Manipal family, known for its excellence in healthcare delivery across India. My vision is to build on the hospital’s strong foundation and bring the most precise and advanced cancer care to patients in Delhi, Gurugram, and Ghaziabad. Through robotics and cutting-edge technology, we aim to deliver safer, minimally invasive, and more effective surgeries, enhancing both survival rates and quality of life.”
Under Dr. Dabas' leadership, the Manipal Comprehensive Cancer Centre is set to become a centre of excellence in cancer care, offering evidence-based treatments, advanced clinical protocols, and a multidisciplinary approach for managing a wide range of cancers.